ShuTodorok's

11.8K posts

ShuTodorok's

ShuTodorok's

@STodo_Rocks

I do not give financial advice. Everything I express is my own opinion. Please do your own due diligence before buying or selling.

가입일 Nisan 2020
288 팔로잉485 팔로워
ShuTodorok's 리트윗함
CrusaderX
CrusaderX@CrusaderStocks·
$BURU News: NUBURU Wins Counter-Drone Directed-Energy Order from Tier-One Government Defense Electronics Organization, Entering Asia-Pacific Defense Market and $20B Global Opportunity businesswire.com/news/home/2026… @nuburulasers @NYSE
CrusaderX tweet media
English
0
2
3
141
SC
SC@S_C1710·
@STodo_Rocks Why do you think it dropped today
English
1
0
0
9
ShuTodorok's 리트윗함
William Paulson
William Paulson@Billerrr1·
$BTBD Earnings — Very Bullish 🚀 BT Brands Reports 2025 Results, Delivers 138% EBITDA Growth and Advances Transformational Aero Velocity Merger Revenue: • Actual: $13,486,629 • YoY Change: -8.95% EPS: • Actual: $(0.11) • YoY Change: +70.27% improvement (loss narrowed from $(0.37)) Key Metrics: • Net Income/Loss: $(687,839) • Gross Margin: 66.67% (Calculated from Sales minus Food and paper costs) • Cash Position: $4,442,290 (Cash and marketable securities) • G&A Expense: $1,464,021 Guidance: No formal financial guidance provided at this time. Bull Case: + **Significant Operational Turnaround:** Restaurant-level EBITDA increased 138% to $1.7 million, operating loss improved approximately 80%, and net loss per share improved 70% YoY. This demonstrates effective cost control and efficiency. + **Transformational Merger Catalyst:** The proposed merger with Aero Velocity, Inc. will reposition BTBD into a high-growth technology and infrastructure platform focused on AI-driven analytics and drone-based inspection services, a highly attractive sector for investors. + **Strong Cash Position:** The Company ended 2025 with approximately $4.4 million in cash and marketable securities, providing financial stability for a small-cap. Bear Case: − **Revenue Decline:** Sales decreased by 8.95% year-over-year, indicating a shrinking core restaurant business, though management attributes this to strategic closure of underperforming locations. − **Merger Completion Risk:** The Aero Velocity merger is subject to stockholder approvals, regulatory approval, and customary closing conditions, presenting an inherent risk of delay or failure. The market will likely react strongly to the combination of BTBD's impressive operational turnaround in its existing business and the significant advancement of the transformational merger into the high-growth AI/drone technology sector. This news provides a powerful narrative for short-term price momentum, overshadowing the revenue decline in the current business as the company strategically shifts focus. #earnings #trading Not financial advice. DYOR.
English
0
1
1
273
ShuTodorok's 리트윗함
Snow
Snow@CloudTrader_·
$BTBD 2025 Highlights and recent developments include: Restaurant-level EBITDA increased 138% to $1.7 million from $723,828 in 2024. Operating loss improved approximately 80% to $(364,585) from $(1.8) million in 2024. Net loss improved to $(687,839), or $(0.11) per share, compared to $(2.3) million, or $(0.37) per share, in 2024. The Company ended the year with approximately $4.4 million in cash and marketable securities. The Company recorded a $216,248 charge to reduce NGI bottled water inventory to estimated net realizable value. BT Brands continues to advance its proposed merger with Aero Velocity, Inc. @greatstockpicks @BigPlaySnipers @Parangiras Some great guys recently covered this one
English
0
1
4
240
ShuTodorok's 리트윗함
SEC Filings Digest
SEC Filings Digest@USCorpFilings·
$RVYL Merger Agreement: RYVYL Inc. reported on March 25, 2026, that it has entered into a proposed merger agreement with RTB Digital, Inc., which includes a $10 million non-refundable deposit as part of a strategic partnership. The merger positions Ryvyl as the surviving entity, with RTB becoming a wholly owned subsidiary, pending resolution of certain terms within 30 days. stockinsights.ai/us/RVYL/8-K/co…
English
0
1
0
5.4K
ShuTodorok's 리트윗함
BiopharmaWatch
BiopharmaWatch@Biopharma_Watch·
Top Market Movers: Negative News Full Access: biopharmawatch.com/market-movers $CNTB [2.73$] [-20.87%] [2026-03-30T11:02:00.000Z] Connect Biopharma Announces $20.2 Million Private Placement Financing
English
4
2
1
202
ShuTodorok's 리트윗함
Ozmosi
Ozmosi@OzmosiHealth·
$PHIO Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762 More Info: pryzm.ozmosi.com/product/25034
Ozmosi tweet media
English
0
1
1
90
ShuTodorok's 리트윗함
BioRestorative Therapies, Inc.
$BRTX announced blinded data from its Phase 2 clinical trial evaluating hypoxic-cultured mesenchymal stem cells for the treatment of chronic lumbar disc disease at the 2026 @ORSsociety Annual Meeting this weekend. Full press release here: bit.ly/4sGF3LP #ORS2026
BioRestorative Therapies, Inc. tweet media
English
5
4
10
393
ShuTodorok's
ShuTodorok's@STodo_Rocks·
$ryvl News out today
ShuTodorok's tweet media
English
0
0
0
35